Page last updated: 2024-10-24

negative regulation of defense response to bacterium

Definition

Target type: biologicalprocess

Any process that stops, prevents or reduces the frequency, rate or extent of defense response to bacterium. [GOC:TermGenie, PMID:22346749]

Negative regulation of defense response to bacterium is a complex biological process that involves the coordinated action of various cellular components and pathways to dampen down the host's immune response to bacterial infection. The goal of this process is to prevent excessive inflammation and tissue damage while still maintaining a sufficient level of defense against the pathogen.

Here's a breakdown of the key components involved:

1. **Sensors:** The host cell first needs to recognize the presence of bacteria. This is accomplished by pattern recognition receptors (PRRs), which are specialized receptors that detect conserved molecular patterns associated with bacteria, such as lipopolysaccharide (LPS) or peptidoglycan.

2. **Signaling Pathways:** Upon recognition of bacterial components, PRRs trigger downstream signaling cascades. These pathways involve a complex interplay of kinases, phosphatases, and adaptor proteins that ultimately lead to the activation of transcription factors.

3. **Transcription Factors:** Activated transcription factors, such as NF-κB, STATs, and IRFs, bind to specific DNA sequences in the promoter regions of target genes, influencing the expression of genes involved in immune response.

4. **Immune Mediators:** Transcriptional regulation leads to the production of a diverse array of immune mediators, including cytokines, chemokines, and antimicrobial peptides. These molecules play crucial roles in orchestrating the host's defense against bacteria.

5. **Negative Regulation:** This is where the negative regulation of defense response to bacterium comes into play. Excessive immune activation can be detrimental, leading to tissue damage and even sepsis. Therefore, negative regulation mechanisms are crucial to ensure an appropriate level of immune response. These mechanisms can involve:
- **Inhibition of PRR signaling:** This can be achieved through the downregulation of PRRs themselves, the activation of inhibitory signaling molecules, or the degradation of signaling components.
- **Suppression of transcription factors:** Negative regulators can directly inhibit the activity of transcription factors, preventing their activation or promoting their degradation.
- **Production of anti-inflammatory cytokines:** Some cytokines, such as IL-10, are known to suppress the production of pro-inflammatory cytokines, helping to dampen the immune response.
- **Induction of immune tolerance:** In some cases, the host may develop tolerance to certain bacterial antigens, preventing an excessive immune response to repeated exposures.

6. **Homeostasis:** Negative regulation mechanisms work to restore homeostasis, preventing uncontrolled immune activation and ensuring that the immune response is tightly controlled and targeted towards the invading bacteria.

7. **Resolution of Infection:** The successful resolution of bacterial infection involves the coordinated action of both positive and negative regulatory mechanisms. The immune response must be strong enough to control the infection but also sufficiently regulated to prevent detrimental consequences.

The complexity of negative regulation of defense response to bacterium underscores the importance of maintaining a delicate balance between protecting the host from infection and preventing excessive inflammation and tissue damage.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Hepatitis A virus cellular receptor 2A hepatitis A virus cellular receptor 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8TDQ0]Homo sapiens (human)
Arginase-2, mitochondrialAn arginase-2, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:P78540]Homo sapiens (human)

Compounds (5)

CompoundDefinitionClassesRoles
n(omega)-hydroxyarginineN(5)-[(Z)-amino(hydroxyimino)methyl]-L-ornithine : An N(5)-[amino(hydroxyimino)methyl]-L-ornithine in which the double bond has Z-configuration.

N(omega)-hydroxyarginine: can cause vasorelaxation of bovine intrapulmonary artery; structure given in first source
amino acid zwitterion;
N(5)-[(E)-amino(hydroxyimino)methyl]ornithine;
N(5)-[(hydroxyamino)(imino)methyl]ornithine;
N(5)-[(Z)-amino(hydroxyimino)methyl]ornithine;
N(5)-[amino(hydroxyimino)methyl]-L-ornithine;
N(5)-[amino(hydroxyimino)methyl]ornithine;
N(omega)-hydroxy-L-arginine
Nomega-hydroxy-nor-l-arginineL-alpha-amino acid
5-chloro-1h-benzimidazole-2-thiol5-chloro-1H-benzimidazole-2-thiol: trypanocidal
(S)-2-amino-6-boronohexanoic acid(S)-2-amino-6-boronohexanoic acid : L-Norleucine substituted at C-6 with a borono group.non-proteinogenic L-alpha-amino acid;
organoboron compound
2-amino-6-boronohexanoic acid